DK0759929T3 - Oxidation af steroider, der har allylgrupper - Google Patents

Oxidation af steroider, der har allylgrupper

Info

Publication number
DK0759929T3
DK0759929T3 DK95920434T DK95920434T DK0759929T3 DK 0759929 T3 DK0759929 T3 DK 0759929T3 DK 95920434 T DK95920434 T DK 95920434T DK 95920434 T DK95920434 T DK 95920434T DK 0759929 T3 DK0759929 T3 DK 0759929T3
Authority
DK
Denmark
Prior art keywords
steroids
oxidation
allyl groups
allylic
delta
Prior art date
Application number
DK95920434T
Other languages
English (en)
Inventor
Ross A Miller
Andrew S Thompson
Raman K Bakshi
Edward G Corley
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Application granted granted Critical
Publication of DK0759929T3 publication Critical patent/DK0759929T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/40—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals of the platinum group metals
    • B01J23/46—Ruthenium, rhodium, osmium or iridium
    • B01J23/462—Ruthenium
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J23/00—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00
    • B01J23/38—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals
    • B01J23/54—Catalysts comprising metals or metal oxides or hydroxides, not provided for in group B01J21/00 of noble metals combined with metals, oxides or hydroxides provided for in groups B01J23/02 - B01J23/36
    • B01J23/56—Platinum group metals
    • B01J23/64—Platinum group metals with arsenic, antimony, bismuth, vanadium, niobium, tantalum, polonium, chromium, molybdenum, tungsten, manganese, technetium or rhenium
    • B01J23/652—Chromium, molybdenum or tungsten
    • B01J23/6527—Tungsten
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95920434T 1994-05-19 1995-05-15 Oxidation af steroider, der har allylgrupper DK0759929T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24593594A 1994-05-19 1994-05-19
PCT/US1995/006004 WO1995032215A1 (en) 1994-05-19 1995-05-15 Oxidation of steroids having allylic groups

Publications (1)

Publication Number Publication Date
DK0759929T3 true DK0759929T3 (da) 2000-11-13

Family

ID=22928693

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95920434T DK0759929T3 (da) 1994-05-19 1995-05-15 Oxidation af steroider, der har allylgrupper

Country Status (22)

Country Link
US (1) US6369247B1 (da)
EP (1) EP0759929B1 (da)
JP (1) JPH10500682A (da)
KR (1) KR970703359A (da)
CN (1) CN1152316A (da)
AT (1) ATE195741T1 (da)
AU (1) AU688513B2 (da)
BR (1) BR9507663A (da)
CA (1) CA2190500A1 (da)
CZ (1) CZ338896A3 (da)
DE (1) DE69518515T2 (da)
DK (1) DK0759929T3 (da)
ES (1) ES2149365T3 (da)
FI (1) FI964610L (da)
GR (1) GR3034201T3 (da)
HU (1) HU223613B1 (da)
NZ (1) NZ287230A (da)
PT (1) PT759929E (da)
RO (1) RO116550B1 (da)
RU (1) RU2149875C1 (da)
SK (1) SK282278B6 (da)
WO (1) WO1995032215A1 (da)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0862556B1 (en) * 1995-10-23 2001-09-05 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives
US5763361A (en) * 1995-10-23 1998-06-09 Merck & Co., Inc. 17-alkyl-7-substituted-4-aza steroid derivatives as 5-α-reductase inhibitors
US5872126A (en) * 1996-09-06 1999-02-16 Merck & Co., Inc. Methods and compositions for treating preterm labor
US6686486B1 (en) 1997-05-07 2004-02-03 Padma Marwah Process for effecting allylic oxidation
US5869709A (en) * 1997-05-07 1999-02-09 Humanetics Corporation Process for effecting allylic oxidation
US6252119B1 (en) * 1997-07-28 2001-06-26 Salvador Jorge Antonio Riberiro Copper-catalysed allylic oxidation using alkyl hydroperoxide
US7012069B2 (en) * 2001-05-03 2006-03-14 Arch Development Corporation Liver X receptor agonists
US6187925B1 (en) 1997-12-23 2001-02-13 Merck & Co., Inc. Intermediates and process for the synthesis of azasteroids
AU3088799A (en) 1998-03-18 1999-10-11 Humanetics Corporation Process for effecting allylic oxidation using dicarboxylic acid imides and chromium reagents
BR0010197A (pt) 1999-04-30 2002-07-16 Arch Dev Corp Derivados de esteróides
GB0020286D0 (en) * 2000-08-18 2000-10-04 Univ York Cobalt catalysed allylic oxidation of unsaturated steroids using alkyl hydroperoxide
US7078396B2 (en) * 2001-05-03 2006-07-18 Arch Development Corporation Method of treating disorder related to high cholesterol concentration
US20070197484A1 (en) * 2001-05-03 2007-08-23 Ching Song Method of treating disorder related to high cholesterol concentration
CA2482195A1 (en) * 2002-04-12 2003-10-23 The University Of Chicago Farnesoid x-activated receptor agonists
US20070032464A1 (en) * 2004-10-08 2007-02-08 Shutsung Liao Methods of treating cancers
SI1856237T1 (sl) * 2005-03-10 2020-12-31 Obagi Cosmeceuticals Llc Stabilne organske sestave peroksida
CA2600547A1 (en) * 2005-03-10 2006-09-21 Jr Chem, Llc Benzoyl peroxide compositions and methods of use
WO2007005471A2 (en) * 2005-06-29 2007-01-11 Jr Chem, Llc Stable organic peroxide compositions
US20090306023A1 (en) * 2005-06-29 2009-12-10 Ramirez Jose E Stable organic peroxide compositions
WO2007002880A2 (en) * 2005-06-29 2007-01-04 Jr Chem, Llc Method of enhanced drug application
US7556820B2 (en) 2005-06-29 2009-07-07 Jr Chem, Llc Stable organic peroxide compositions
CN101619089B (zh) * 2009-07-28 2011-07-20 陈大刚 抗肿瘤药物cl168、其合成方法及应用
CN102482315A (zh) * 2009-07-29 2012-05-30 芝加哥大学 肝x受体激动剂
US9561479B2 (en) * 2011-01-31 2017-02-07 Asahi Kasei Chemicals Corporation Apparatus for producing mixed solution and method for preparing mixed solution
WO2013101719A2 (en) 2011-12-27 2013-07-04 Northeast Ohio Medical University Amooranin compounds and analogs thereof and related methods of use
CA2907320A1 (en) * 2013-03-15 2014-09-18 Prevacus, Inc. Synthesis of ent-progesterone and intermediates thereof
CN103788163B (zh) * 2014-01-27 2015-11-18 浙江大学 7-酮基甾类化合物的制备方法
CN108698987B (zh) 2015-11-23 2021-07-13 乐巢拓普有限公司 1,4-二烯体系的位点特异性同位素标记
CN106008423B (zh) * 2016-06-24 2018-02-02 云南民族大学 一种苯丙素类化合物及其制备方法和应用
KR20260018193A (ko) 2020-02-21 2026-02-06 레트로토프 인코포레이티드 고도불포화 지방산 및 이의 유도체의 동위원소 변형을 위한 공정
CN118957676B (zh) * 2024-07-29 2026-03-03 中国石油大学(华东) 一种多酸衍生的钨掺杂钌氧化物纳米颗粒电催化剂的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
GB8422443D0 (en) 1984-09-05 1984-10-10 British Petroleum Co Plc Oxidation of hydrocarbons
DK173704B1 (da) 1985-04-17 2001-07-09 Hoffmann La Roche Fremgangsmåde til katalytisk oxidation af allyliske grupper
HUT71484A (en) 1992-05-20 1995-11-28 Merck & Co Inc Process for producing of 7beta-substituted-4-aza-5alpha-cholestan-ones as 5-alpha-reductase inhibitors and pharmaceuticals compositions containing them
IL111467A0 (en) 1993-11-12 1994-12-29 Merck & Co Inc Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors

Also Published As

Publication number Publication date
CN1152316A (zh) 1997-06-18
FI964610A0 (fi) 1996-11-18
ATE195741T1 (de) 2000-09-15
RU2149875C1 (ru) 2000-05-27
KR970703359A (ko) 1997-07-03
CA2190500A1 (en) 1995-11-30
SK147896A3 (en) 1997-08-06
EP0759929A1 (en) 1997-03-05
AU2588595A (en) 1995-12-18
AU688513B2 (en) 1998-03-12
HU223613B1 (hu) 2004-10-28
NZ287230A (en) 1997-07-27
HU9603187D0 (en) 1997-01-28
DE69518515D1 (de) 2000-09-28
WO1995032215A1 (en) 1995-11-30
PT759929E (pt) 2001-01-31
SK282278B6 (sk) 2002-01-07
JPH10500682A (ja) 1998-01-20
FI964610A7 (fi) 1996-11-18
HK1009274A1 (en) 1999-05-28
EP0759929B1 (en) 2000-08-23
DE69518515T2 (de) 2001-04-19
CZ338896A3 (en) 1997-07-16
BR9507663A (pt) 1997-10-07
HUT75778A (en) 1997-05-28
EP0759929A4 (en) 1998-09-30
RO116550B1 (ro) 2001-03-30
GR3034201T3 (en) 2000-11-30
FI964610L (fi) 1996-11-18
US6369247B1 (en) 2002-04-09
ES2149365T3 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
FI964610A0 (fi) Allyyliryhmiä sisältävien steroidien hapetus
ES2101942T3 (es) Procedimiento de epoxidacion.
ES2028860T3 (es) Catalizador para oxido de etileno y procedimiento para la produccion catalitica de oxido de etileno.
DE60127344D1 (de) Katalysator und Verfahren zur Herstellung von Wasserstoffperoxid
TR199801084T2 (xx) Oksijenat d�n���m�nde ge�i� metali ihtiva eden k���k g�zenekli molek�ler elekli kataliz�rlerin kullan�m�.
DE68921777D1 (de) Hochwirksame Silberkatalysatoren zur Herstellung von Ethylenoxid durch Ethylenoxidation.
ATE212612T1 (de) Verfahren zur oxidation einer mindestens eine c-c-doppelbindung aufweisenden organischen verbindung
ES2150574T3 (es) Separacion por membranas.
DE69839728D1 (de) Ethylenoxid-katalysatoren
TW429163B (en) Oxidazing catalyst system and an oxidation process by using the same
AR018802A1 (es) Procedimiento de preparacion de un oxirano
ES2182148T3 (es) Metodo de epoxidacion de polimeros insaturados.
DE3769756D1 (de) Katalytische entfernung von peroxidverunreinigungen aus tert. butylalkohol.
ATE31287T1 (de) Verfahren zur herstellung von wasserstoffperoxid.
ES2096372T3 (es) Procedimiento para la obtencion de formaldehido mediante deshidratacion oxidativa de metanol en presencia de oxido de dinitrogeno.
MX157218A (es) Produccion de etilen-glicol por la reaccion de metano,un peroxido organico y formaldehido
DE60114663D1 (de) Verfahren zur herstellung von organischen hydroperoxiden mit verringertem anteil an verunreinigungen
ES2057783T3 (es) Procedimiento en dos etapas para endulzar una fraccion hidrocarbonada sulfurada.
ATE151431T1 (de) Herstellung von n-phosphonomethylglysin und derensalze
ES2135143T3 (es) Procedimiento para la fabricacion de pentenales.
MX9605718A (es) Oxidacion de esteroides que tienen grupos alilicos.
EP0934114A4 (en) ACTIVATED SILVER CATALYST
DK341283A (da) Fremgangsmaade til oxidation af vinylbenzen-forbindelser til beta-phenylaldehyder
DE50101047D1 (de) Verfahren zur herstellung von epoxiden durch oxidation von olefinen
BR0109260A (pt) Processo de oxidação de hidrocarbonetos